SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

SCHEDULE 13D

(Rule 13d-101)

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 14)

MINDBODY, Inc.

(Name of Issuer)

Class A Common Stock, par value $0.000004 per share

(Title of Class of Securities)

60255W105

(CUSIP Number)

with a copy to:

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

November 30, 2017

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box.  ☐

Note. Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

2

3

4

5

6

CUSIP No. 60255W105

SCHEDULE 13D (FINAL AMENDMENT)

This Amendment No. 14 (“Amendment No. 14”) amends and supplements the Schedule 13D filed on December 4, 2015 (the “Original Schedule 13D”) as amended by Amendment No. 1 thereto on February 10, 2016 (“Amendment No. 1”), Amendment No. 2 thereto on February 12, 2016 (“Amendment No. 2”), Amendment No. 3 thereto on February 17, 2016 (“Amendment No. 3”), Amendment No. 4 thereto on March 7, 2016 (“Amendment No. 4”), Amendment No. 5 thereto on July 28, 2016 (“Amendment No. 5”), Amendment No. 6 thereto on August 8, 2016 (“Amendment No. 6”), Amendment No. 7 thereto on October 3, 2016 (“Amendment No. 7”), Amendment No. 8 thereto on October 13, 2016 (“Amendment No. 8”), Amendment No. 9 thereto on October 27, 2016 (“Amendment No. 9”), Amendment No. 10 thereto on February 9, 2017 (“Amendment No. 10”), Amendment No. 11 thereto on May 1, 2017 (“Amendment No. 11”), Amendment No. 12 thereto on June 1, 2017 (“Amendment No. 12”) and Amendment No. 13 thereto on July 7, 2017 (“Amendment No. 13” and, together with the Original Schedule 13D, Amendment No. 1, Amendment No. 2, Amendment No. 3, Amendment No. 4, Amendment No. 5, Amendment No. 6, Amendment No. 7, Amendment No. 8, Amendment No. 9, Amendment No. 10, Amendment No. 11 and Amendment No. 12, the “Schedule 13D”), relating to the shares of Class A common stock, par value $0.000004 per share (the “Common Stock”), of MINDBODY, Inc. (the “Issuer”). Each Item below amends and supplements the information disclosed under the corresponding Item of the Schedule 13D. Except as specifically provided herein, this Amendment No. 14 does not modify any of the information previously reported in the Schedule 13D. Capitalized terms used but not defined in this Amendment No. 14 shall have the same meanings herein as are ascribed to such terms in the Schedule 13D.

Item 4. Purpose of Transaction

Item 4 of the Schedule 13D is hereby supplemented by adding the following:

On November 30, 2017, the Reporting Persons sold a portion of their Common Stock in a block trade, as described in further detail in Item 5 below. The sale was undertaken for portfolio management purposes.

Item 5. Interest in Securities of the Issuer.

Item 5 of the Schedule 13D is hereby amended by amending and restating paragraphs (a) and (b) thereof as follows:

(a) The information requested by this paragraph is incorporated herein by reference to the information provided on the cover pages to this Amendment No. 14.

(b) The information requested by this paragraph is incorporated herein by reference to the information provided on the cover pages to this Amendment No. 14 and Item 2(c) of the Schedule 13D.

Item 5(c) of the Schedule 13D is hereby supplemented by adding the following:

(c) On November 30, 2017, the Reporting Persons sold an aggregate of 1,000,000 shares of Common Stock in a block trade at a price per share of $31.85. Except as described in the immediately preceding sentence, there were no transactions in the Common Stock effected by the Reporting Persons during the past sixty days.

Item 5(e) of the Schedule 13D is hereby amended and restated as follows:

(e) As a result of the transaction described in Item 5(c), on November 30, 2017, none of the Reporting Persons beneficially owned more than five percent of the Issuer’s Common Stock.

7

CUSIP No. 60255W105

SIGNATURES

After reasonable inquiry and to the best of their knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.

Dated: December 1, 2017

8